About Orthopediatrics (NASDAQ:KIDS)
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, locking cannulated blades, locking proximal femurs, spica tables, response spine systems, and pediguards; bandloc, a sub-laminar banding system; and sports medicine and other products, such as anterior cruciate ligament and medial patellofemoral ligament systems. Its products are used in the pediatric trauma and deformity procedures, as well as scoliosis procedures for the treatment of spinal deformity. The company serves pediatric orthopedic market, as well as caregivers. OrthoPediatrics Corp. was founded in 2007 and is headquartered in Warsaw, Indiana.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Trailing P/E Ratio-3.62
Forward P/E Ratio-29.85
Sales & Book Value
Annual Sales$45.62 million
Price / Sales5.51
Price / CashN/A
Book Value$3.74 per share
Price / Book5.27
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Orthopediatrics (NASDAQ:KIDS) Frequently Asked Questions
What is Orthopediatrics' stock symbol?
Orthopediatrics trades on the NASDAQ under the ticker symbol "KIDS."
How were Orthopediatrics' earnings last quarter?
Orthopediatrics Corp (NASDAQ:KIDS) released its earnings results on Wednesday, March, 7th. The company reported ($3.93) earnings per share for the quarter, missing analysts' consensus estimates of ($0.13) by $3.80. The firm earned $11.68 million during the quarter, compared to analysts' expectations of $11.45 million. View Orthopediatrics' Earnings History.
When is Orthopediatrics' next earnings date?
What price target have analysts set for KIDS?
4 brokers have issued 1 year target prices for Orthopediatrics' stock. Their forecasts range from $23.00 to $24.00. On average, they expect Orthopediatrics' stock price to reach $23.6667 in the next twelve months. View Analyst Ratings for Orthopediatrics.
Who are some of Orthopediatrics' key competitors?
Some companies that are related to Orthopediatrics include SurModics (SRDX), Inovio Pharmaceuticals (INO), Accuray (ARAY), Utah Medical Products (UTMD), Antares Pharma (ATRS), Endologix (ELGX), GenMark Diagnostics (GNMK), Tandem Diabetes Care (TNDM), Pulse Biosciences (PLSE), T2 Biosystems (TTOO), Cytosorbents (CTSO), Nuvectra (NVTR), SeaSpine (SPNE), Iradimed (IRMD), Restoration Robotics (HAIR), Apollo Endosurgery (APEN), Alphatec (ATEC) and Invuity (IVTY).
Who are Orthopediatrics' key executives?
Orthopediatrics' management team includes the folowing people:
- Mr. Mark C. Throdahl, CEO, Pres & Director (Age 67)
- Mr. Fred L. Hite, CFO & Director (Age 50)
- Mr. David R. Bailey, Exec. VP (Age 39)
- Mr. Gregory A. Odle, Exec. VP of Commercialization (Age 48)
- Mr. Daniel J. Gerritzen, VP of Legal & HR, Gen. Counsel and Sec. (Age 48)
When did Orthopediatrics IPO?
(KIDS) raised $52 million in an initial public offering on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers.
When did Orthopediatrics' lock-up period expire?
Orthopediatrics' lock-up period expired on Tuesday, April 10th. Orthopediatrics had issued 4,000,000 shares in its public offering on October 12th. The total size of the offering was $52,000,000 based on an initial share price of $13.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the expiration of the lock-up period.
Has Orthopediatrics been receiving favorable news coverage?
News stories about KIDS stock have been trending somewhat positive on Friday, according to Accern Sentiment. The research group ranks the sentiment of media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Orthopediatrics earned a news sentiment score of 0.22 on Accern's scale. They also assigned press coverage about the company an impact score of 46.94 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.
How do I buy shares of Orthopediatrics?
Shares of KIDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Orthopediatrics' stock price today?
One share of KIDS stock can currently be purchased for approximately $19.70.
How big of a company is Orthopediatrics?
Orthopediatrics has a market capitalization of $257.46 million and generates $45.62 million in revenue each year. The company earns $-8,930,000.00 in net income (profit) each year or ($5.70) on an earnings per share basis. Orthopediatrics employs 69 workers across the globe.
How can I contact Orthopediatrics?
Orthopediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The company can be reached via phone at 574-268-6379 or via email at [email protected]
MarketBeat Community Rating for Orthopediatrics (KIDS)MarketBeat's community ratings are surveys of what our community members think about Orthopediatrics and other stocks. Vote "Outperform" if you believe KIDS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KIDS will underperform the S&P 500 over the long term. You may vote once every thirty days.
Orthopediatrics (NASDAQ:KIDS) Earnings History and Estimates Chart
Orthopediatrics (NASDAQ:KIDS) Earnings Estimates
2018 EPS Consensus Estimate: ($0.25)
2019 EPS Consensus Estimate: ($0.10)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Orthopediatrics (NASDAQ KIDS) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|6/6/2018|| || || || || || || || |
|3/7/2018||Q4 2017||($0.13)||($3.93)||$11.45 million||$11.68 million||View||N/A|
|11/8/2017||Q3 2017||($0.12)||($1.70)||$12.13 million||$12.38 million||View||N/A|
Orthopediatrics (NASDAQ:KIDS) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Orthopediatrics (NASDAQ KIDS) Insider Trading and Institutional Ownership History
Institutional Ownership Percentage: 32.34%
Orthopediatrics (NASDAQ KIDS) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|4/13/2018||Daniel J Gerritzen||General Counsel||Sell||11,145||$17.92||$199,718.40|| |
|4/13/2018||David R Bailey||Insider||Sell||30,231||$17.92||$541,739.52|| |
|4/13/2018||Fred Hite||CFO||Sell||29,471||$17.92||$528,120.32|| |
|3/12/2018||David R Pelizzon||Director||Buy||1,000||$17.50||$17,500.00|| |
|10/16/2017||Harold Ruf||Director||Buy||11,500||$13.00||$149,500.00|| |
Orthopediatrics (NASDAQ KIDS) News Headlines
Orthopediatrics (NASDAQ:KIDS) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Orthopediatrics (NASDAQ:KIDS) Income Statement, Balance Sheet and Cash Flow Statement
Orthopediatrics (NASDAQ KIDS) Stock Chart for Friday, April, 20, 2018